Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Zogenix and Battelle have signed an agreement to jointly develop and commercialise Zogenix's DosePro drug delivery technology to pharmaceutical and government clients.
Subscribe to our email newsletter
The DosePro system is designed for self-administration of a pre-filled, single dose of liquid drug, subcutaneously, without a needle.
DosePro needle-free system delivers larger dose viscous drug formulations with increased safety and convenience compared to needle-based injection.
Battelle Health and Life Sciences Global Business president Barbara Kunz said the collaboration enables Battelle to expand the company’s platform of drug delivery solutions to the pharmaceutical customers.
"We believe DosePro will be able to assist our clients with addressing many of the challenges they face today, in particular, the delivery of highly viscous drug formulations," Kunz added.